BioAtla, Inc. (BCAB) Tops Q2 EPS by 1c
BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.